US 10968178
IP6K inhibitors
granted A61PA61P3/10A61P9/00
Quick answer
US patent 10968178 (IP6K inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P3/10, A61P9/00, A61P9/04